1. Relapsed/Refractory Myeloma: Foundational Knowledge Essential to Improve Patient Outcomes

4. Case Study

11. Relapsed Multiple Myeloma What Do You Do With Patients After RVD?

13. Cytogenetics A Parameter That, in Isolation, Should Be Used With Caution

19. Should Consolidation Therapy Be Considered After HDT/ASCT? Yes!

20. Relapsed and/or Refractory MM When to Use the Next Generation of the Existing Class of Agents and When to Use a New Class of Agents

21. Relapsed and/or Refractory MM Novel mAbs

23. Relapsed and/or Refractory MM Novel Proteasome Inhibitors

25. Relapsed and/or Refractory MM Pomalidomide, a Third-Generation IMiD

27. Relapsed and/or Refractory MM Small Molecule Inhibitors

31. Thank you for participating in this activity.